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ABSTRACT  
BACKGROUND For female marathon runners’ breast pain (mastalgia) may be an 
important issue which has yet to be considered. This study aimed to determine the 
prevalence and severity of mastalgia in female marathon runners, identify factors 
that increase mastalgia and methods used to overcome mastalgia, and explore the 
impact that mastalgia may have on marathon training. 
METHODS 1397 female marathon runners were surveyed at the 2012 London 
Marathon Registration. All participants who completed the four part, 30 question 
survey in its entirety have been included in the analysis (n = 1285). 
RESULTS 32% of participants experienced mastalgia. This was significantly related 
to cup size and was greater during vigorous compared to moderate physical activity. 
Exercise-related factors were the primary factors reported to increase mastalgia 
participation. 17% of symptomatic participants reported that mastalgia affected their 
exercise behaviour. Methods reportedly used to overcome mastalgia included pain 
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medication and firm breast support; however 44% of participants took no measures 
to relieve symptoms despite over half describing their mastalgia as discomforting. 
CONCLUSION Mastalgia was experienced by a third of marathon runners and was 
found to be related to breast size which has previously been unreported. The link 
between exercise and mastalgia has yet to be established, however this study 
identified that exercise was the most prevalent factor in mastalgia occurrence which 
may have implications for its management. The number of participants who took no 
measures to relieve their mastalgia, or resorted to pain medication, highlights the 
importance and significance of research into exercise-related mastalgia. 
 
WHAT ARE THE NEW FINDINGS 
 A third of female marathon runners experienced mastalgia which increased with 
cup size, body mass index and activity level, but was not related to age. 
 Over half of symptomatic females described the severity of mastalgia as 
discomforting however 44% had done nothing to relieve their symptoms.  
 Seventeen percent of females reported that their mastalgia resulted in changes in 
their exercise behaviour. 
HOW MIGHT IT IMPACT ON CLINICAL PRACTICE IN THE NEAR FUTURE? 
 The results highlight the need for the advancement of appropriate and effective 
treatment methods of mastalgia and may aid the development of educational 
initiatives for females and health practitioners to effectively manage mastalgia 
symptoms. 
 The link between exercise and mastalgia has yet to be established, however this 
study identified that exercise was the most prevalent factor in mastalgia 
occurrence which may have implications for its management. 
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INTRODUCTION 
 
Mastalgia is a common health experienced by up to two thirds of the general female 
population.[1-2] Mastalgia can impact the health and well-being of females interfering 
with social, physical and sexual and work-related activities.[3-4] Most clinical 
classifications distinguish between non-cyclic and cyclic mastalgia.[5] Non-cyclic 
mastalgia is defined as constant or intermittent pain that is unrelated to the 
menstrual cycle.[6-7] Cyclic mastalgia is thought to have a hormonal etiology and is 
most prominent towards the end of the menstrual cycle.[5,8-9] A third type of 
mastalgia has been identified and is classified as extramammary pain, which is felt 
within the breast but originates from the chest wall or other sources.[6,10] 
Additionally, excessive breast motion during physical activity has been reported to 
result in exercise-related mastalgia.[11-13] 
 
After a thorough breast health history, breast examination and in some instances 
breast imaging, education and reassurance are considered as a first line treatment 
for mastalgia.[1,14-15] A variety of other treatment modalities have been 
investigated, however these have varied results and the placebo response in most 
trials is significant.[10] Pharmacological management of mastalgia is not indicated as 
a first line treatment as commonly prescribed medications (tamoxifen, danazol and 
bromocriptine) are often poorly tolerated and provide only temporary relief.[5,10,16] 
Other approaches include diet and nutritional intervention, however despite fat and 
caffeine being identified as causal factors of mastalgia, limited research has 
investigated the efficacy of reducing fat intake,[17] and reducing caffeine intake is 
not advocated.[10] In a retrospective audit of the efficacy of surgery in severe 
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mastalgia Davies et al.[18] reported that less than 1% of 1054 patients had surgery 
for mastalgia. Furthermore, high complication and relapse rates were evident 
following surgery. In contrast, wearing a well-fitting supportive bra has been reported 
to relieve mastalgia symptoms in 85% of patients with no associated side-effects [9] 
and is recommended for the relief of cyclic and non-cyclic mastalgia.[10] 
 
Appropriate breast support is particularly important for exercising females due to the 
limited anatomical support.[19] This lack of intrinsic breast support can cause 
excessive breast motion during physical activity[11-13,20-22] and is hypothesised to 
increase tension and stretching of the supporting structures of the breast leading to 
exercise-induced mastalgia.[9,11,20-22] Up to 72% of exercising females are 
reported to experience exercise-induced mastalgia[23] and although the mechanical 
properties of suspensory structures of the breast are unknown, greater strain on the 
breast is reported during running compared to walking[24] and it was approximated 
that maximum breast loading could reach up to 50N during running.[19]  
 
Marathon running has increased in popularity among individuals of all ages and 
abilities in recent years [25-27] with an exponential rise observed in female marathon 
participation. [28] Previous studies of marathon runners have focused on a variety of 
physical,[26,29] physiological,[30-32] and psychological[33] implications of marathon 
training and participation. For female marathon runners mastalgia may be an 
important issue which has yet to be considered, but may have implications in terms 
of performance, participation and discomfort during exercise. However no literature 
has investigated mastalgia in a marathon population.[26]  
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Therefore this study aims to: 
 Determine the prevalence and severity of mastalgia in female marathon 
runners. 
 Identify factors that increase mastalgia and report the methods currently 
utilised to overcome mastalgia. 
 Explore the impact that mastalgia may have on exercise behaviour. 
 
METHODS 
 
Following full institutional ethical approval, a four-part, 30 question survey (including 
participant information sheet) was administered to a convenience sample of females 
passing through the registration zone at the 2012 London Marathon exhibition. To 
ensure a high return rate surveys were completed immediately, and collected. All 
data were anonymous. An on-line survey was made available to participants that 
declined the invitation to complete the survey. The questions and format of the on-
line survey were identical to the paper-based survey to demonstrate equivalency and 
increase reliability of the mixed-mode strategy.[34] The on-line survey remained 
accessible for two weeks following the survey. Ethically approved prize draw entry 
(£250 of generic high street vouchers) was offered to all participants on completion 
of the survey as an incentive to increase response rate.[35-36]  
 
The survey included multiple-choice, likert scale and free-text format questions and 
was designed to take no more than 10 minutes to complete. Section 1 of the survey 
identified the physical activity history [37] and marathon experience of participants. 
Section 2 explored breast support considerations of participants, the results of which 
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are reported elsewhere. Section three of the survey focused on mastalgia and was 
an adaptation of the McGill Pain Questionnaire,[38] with extended questions to 
explore methods used to relieve mastalgia and the impact that mastalgia may have 
on marathon training. Section 4 identified demographic data and information about 
breast health history. Minor amendments were made to wording and question order 
prior to use, following a pilot-test on amateur runners (n = 10).  
 
A total of 1397 surveys were collected and following standardised training, a team of 
researchers inputted survey responses into Microsoft Excel (2010). The dataset had 
few missing data and items with missing values were listwise deleted, resulting in a 
final sample size of 1285 for all subsequent analyses. Participants had an average 
body mass [standard deviation (SD)] of 62.7 kg (± 8.9 kg), stature 1.65 m (± 0.7 m), 
and body mass index (BMI) of 22.9 kg.m-2 (± 3.0 kg.m-2). Cup size ranged from an 
AA cup to an HH cup with underband size ranging from 28 to 40 inches. In total fifty-
six bra sizes were reported with a mode bra size of 34B (15.5%). 91% of participants 
reported always wearing a sports bra during running and 86% considered wearing a 
sports bra to be essential.  
 
Data analysis 
Data were analysed descriptively to summarise participant’s demographic profiles 
and prevalence of mastalgia. All statistical analyses were performed using Predictive 
Analytic Software PASW) statistics computer package with statistical significance set 
at 0.05. Non-parametric differences in self-reported physical characteristics, physical 
activity history and predicted marathon finish time of symptomatic and asymptomatic 
participants were assessed using multiple Mann-Whitney U tests. Wilcoxon Signed 
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rank tests were used to identify differences in the prevalence of mastalgia in 
moderate and vigorous physical activity. Chi-squared analysis was used to assess 
the association of mastalgia with cup size, age, and physical activity level. Cup sizes 
AA and A (≤A) and FF to HH inclusive (≥FF) condensed to meet Chi-square 
assumptions.[39] The half decade groups of 60 to 64 years, 65 to 69 years and 70 to 
74 years were also condensed to one group (≥ 60 years) to create 9 age groups.  
 
RESULTS 
 
Prevalence and severity of mastalgia 
Almost one-third (32%) of participants reported experiencing mastalgia (Fig.1) and 
this was significantly related to cup size (X2 = 17.432, p < 0.05) increasing linearly 
(Fig.1).  Mastalgia was not related to participant’s age (X2 = 9.839, p > 0.05).  
 
 
Fig. 1. Prevalence of mastalgia across breast cup size (n = 1279*) 
*6 people reported not knowing their cup size 
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There were no significant differences in the physical activity history and marathon 
experience of symptomatic and asymptomatic participants, however BMI was 
significantly lower in asymptomatic participants (z = -3.046, p < 0.05) (Table 1). 
 
Table 1. Self-reported physical characteristics, physical activity history and marathon 
experience of symptomatic (n = 412) and asymptomatic (n = 837) participants  
 
 
 
Symptomatic 
(n = 412) 
Asymptomatic 
(n  =873) 
All 
(n = 1285) 
Stature (m) 1.65 ± 0.7 1.65 ± 0.7 1.65 ± 0.7 
Body mass (kg) 63.2 ± 9.4 62.4 ± 8.6 62.7 ± 8.9 
Body mass index (kg.m-2) 23.1 ± 3.1 22.8 ± 2.9* 22.9 ± 3.0 
Duration of typical exercise session (mins)      
      Moderate intensity 70.1 ± 45.6 74.3 ± 53.2 72.9 ± 50.9 
      Vigorous intensity 73.5 ± 58.1 68.8 ± 50.2 70.3 ± 52.9 
Number of days exercise in a typical week      
      Moderate intensity 3.8 ± 1.7 3.9 ± 1.6 3.8 ± 1.7 
      Vigorous intensity 3.0 ± 1.7 2.9 ± 1.6 2.9 ± 1.6 
Predicted marathon finish time (mins)      
      London 2012 marathon 284.7 ± 44.6 281.6 ± 45.1 282.6 ± 45.0 
Marathons previously completed n (%) n (%) n (%) 
      London 2012 first marathon 244 (59%) 486 (56%) 730 (57%) 
      1 -2 marathons 107 (26%) 208 (24%) 315 (24%) 
      3 - 4 marathons 24 (6%) 89 (10%) 113 (9%) 
      ≥ 5 marathons 37 (9%) 90 (10%) 127 (10%) 
All values are presented as mean ± SD unless otherwise stated. Moderate intensity (activities 
requiring moderate physical effort and causing small increases in breathing or heart rate and vigorous 
intensity (activities requiring hard physical effort and large increases in breathing or heart rate). 
*denotes significant difference at < 0.05 level 
 
Forty-six percent of participants reported that they had given birth to one or more 
children, of whom 88% reported they had breast fed their child/children. Mastalgia 
was significantly related to parity (X2= 7.753, p < 0.05) with significantly more 
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nulliparous participants experiencing mastalgia (35%) compared to parous 
participants (28%). 
 
Of the 412 (32%) participants that reported experiencing mastalgia 52% reported 
that this was related to their menstrual cycle, and 30% that it was sometimes related 
to their menstrual cycle. The severity, distress level, frequency and duration of 
mastalgia reported by participants is shown in Table 2. Over half (52%) of 
symptomatic participants described the severity of their mastalgia as discomforting, 
with a further 8% reporting the severity as either distressing, horrible, or excruciating. 
Nearly three-quarters (74%) of participants reported some level of distress as a 
consequence of mastalgia.  
 
Table 2. Severity, distress level, frequency and duration of mastalgia (n = 412) 
Severity of 
mastalgia 
Mild Discomforting Distressing Horrible Excruciating 
40% 52% 5% 2% 1% 
Distress level 
of mastalgia 
Not at all A little bit Somewhat Quite a bit Very much 
26% 54% 15% 4% 1% 
Frequency of 
mastalgia 
Hourly Daily Weekly Monthly 2-3 months 
3% 11% 8% 47% 31% 
Duration of 
mastalgia 
Momentary Brief Transient Steady Continuous 
12% 34% 28% 20% 6% 
 
The prevalence of mastalgia was reported to be significantly lower in moderate 
physical activity compared to vigorous physical activity (Z = -7.931, p < 0.05) with 
54% of participants experiencing mastalgia during moderate physical activity, 
compared to 64% during vigorous physical activity (Fig.2). 
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Fig. 2. Prevalence of mastalgia in moderate and vigorous physical activity (n = 412) 
Moderate intensity (activities requiring moderate physical effort and causing small increases in 
breathing or heart rate) and vigorous intensity (activities requiring hard physical effort and large 
increases in breathing or heart rate 
 
Factors reported to increase mastalgia and methods utilised to relieve 
mastalgia 
The most prevalent factors reported to increase participants’ mastalgia were related 
to exercise participation (14%) (Fig.3). Hormonal/menstrual related factors were 
reported by 12% of participants and bra related factors such as wearing an ill-fitting 
and/or unsupportive bra were reported by 10% of participants. 
 Fig. 3: Factors reported to increase mastalgia (n = 412)  
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Participants were given the opportunity to select from a range of factors that they 
had used to relieve mastalgia, in addition to providing free-text responses (Fig.4). 
44% of participants reported having taken no measures to relieve their mastalgia. A 
variety of methods were reportedly used by the remaining participants to relieve 
mastalgia, with the most popular sports bra use (21%) pain medication (15%) and 
holding the breast (14%).  
 
 Fig. 4. Measures taken to overcome mastalgia (n = 412) 
  
 
Impact of mastalgia on exercise behaviour 
Of the 412 participants that experienced mastalgia, 17% reported that mastalgia 
affected their participation in exercise. Of these, 29% reported that it rarely affected 
their participation, 57% sometimes, 10% very often and 3% always. Figure 5 
identifies the participants’ changes in exercise behaviour as a result of mastalgia. 
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 Fig. 5. Changes made to exercise behaviour due to mastalgia (n = 70)*** 
 
DISCUSSION 
 
Prevalence and severity of mastalgia 
A third of female marathon runners experienced mastalgia. Over half of these 
participants described the severity of mastalgia as discomforting and reported some 
level of distress as a consequence of mastalgia. This highlights the need to 
investigate this important quality of life issue for exercising women. The prevalence 
of mastalgia increased with cup size, ranging from 24% in participants with ≤ A cup 
size breasts to 51% in participants with ≥ F cup size breasts. This is an important 
finding as it has yet to be established whether breast size is related to mastalgia, due 
to the small sample sizes in previous studies. Furthermore, it indicates that the 
condition is not restricted to only larger-breasted women. The prevalence of 
mastalgia in the present study was also higher in nulliparous participants compared 
to parous participants. The breast reaches its most differentiated status following 
parturition [40-41] and investigating the variation in breast composition at different 
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life stages and the association of composition with mastalgia may also provide 
further insight into the etiology and management of mastalgia. 
 
Over a fifth of symptomatic participants reported experiencing mastalgia at some 
time during exercise. This highlights the need for the advancement of appropriate 
and effective treatment methods of mastalgia to allow females to exercise in comfort, 
and confirms the significance and importance of research into exercise-related 
mastalgia. Participants reported experiencing mastalgia significantly more frequently 
during vigorous physical activity compared to moderate physical activity. The 
suggests that activity-level specific support may have implications with regard to 
mastalgia, although further understanding of this association is needed in order to 
inform breast support design. 
 
It could be suggested that female runners who did not experience mastalgia may 
have viewed their participation in the study as redundant, and thus declined to take 
part in the study. Consequently the prevalence of mastalgia in female marathon 
runners may be lower than one third. However, the survey focused on a number of 
areas related to the breast, and was described as a breast health questionnaire, thus 
avoiding a specific focus on mastalgia. Additionally the face-to-face recruitment 
methodology employed resulted in a high response rate representing 10% of all 
female runners in the 2012 London Marathon. 
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Factors reported to increase mastalgia and methods utilised to overcome 
mastalgia 
Exercise related factors were most commonly reported to increase mastalgia in 
female marathon runners. It is therefore important to identify appropriate strategies 
and treatment modalities to reduce mastalgia when exercising, in order to allow 
women to exercise in comfort. Hormonal/menstrual related factors were also 
reported to increase mastalgia, supporting previous research that indicates 
mastalgia is hormonally mediated.[5,8-9]. An ill-fitting and/or unsupportive bra was 
reported by 10% of participants to increase mastalgia highlighting the importance of 
appropriate, well-fitting breast support. As suggested by White & Scurr[42] 
educational initiatives to aid women in selecting appropriate, correctly fitting breast 
support are warranted. The benefits of a well-fitted sports bra in reducing mastalgia 
and breast motion are well documented[9,11,20-22]  and in the present study the 
use of a sports bra was the most commonly reported method used to relieve 
mastalgia  (21%). However 91%  of participants reporting always wearing a sports 
bra when running suggesting that sports bra use is not necessarily perceived as a 
method to treat mastalgia, and that sports bra design and manufacture needs 
improvement.  
 
Although pharmacological treatments can provide temporary relief of mastalgia, this 
can be associated with negative side effects and should only be considered when 
first line treatments are ineffective [10]. However, the second most commonly used 
method to relieve mastalgia in the present study was pain medication (15%). This 
highlights the importance and significance of research into the treatment of mastalgia 
and demonstrates the need for prospective evaluation into treatment modalities. This 
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is further evidenced by the 44% of participants who reported taking no measures to 
overcome mastalgia. 
 
Impact of mastalgia on exercise behaviour 
In the present study 17% of participants experiencing mastalgia reported that it 
influenced their participation in exercise. The interference of mastalgia on physical 
activity has previously been reported to range between 29%[1] and 37%[3] however 
it is noted that these studies comprised of clinic-based samples as opposed to highly 
active individuals and were conducted over 16 years ago. Elevated pain thresholds 
and pain tolerance in marathon runners have been reported,[43] which may partly 
explain the lower prevalence of mastalgia in the present study. Furthermore, it could 
be postulated that due to the intense demands of marathon training some individuals 
experiencing mastalgia may have been unable to race/complete training, resulting in 
an under-estimation of the impact of mastalgia on exercise participation.  
Beyond reporting the influence of mastalgia on normal physical activity levels, 
precise changes to exercise behaviour as a result of mastalgia have not been 
previously investigated. Over a quarter of female marathon runners experiencing 
mastalgia in the present study reduced the intensity of their exercise and a fifth had 
missed an exercise session as a result of mastalgia. Other changes included 
reducing the duration of activity, participating in an alternative activity, or re-
scheduling. These results suggest that for some, mastalgia may have negative 
consequences on marathon preparation, and thus is an issue to address. 
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CONCLUSION 
In conclusion, the results of this large scale survey suggest that a third of female 
marathon runners experience mastalgia. Additionally mastalgia was found to be 
significantly related to breast size which has previously been undetermined. Exercise 
was the primary factor reported to increase mastalgia, highlighting the importance 
and significance of research in to exercise-related mastalgia to allow women to 
exercise in greater comfort. Over half of symptomatic women described the severity 
of mastalgia as discomforting and three-quarters reported some level of distress as a 
consequence of mastalgia. Despite this, just under half of the women had taken no 
action to relieve their symptoms. The link between exercise and mastalgia has yet to 
be established, however, this study identified that exercise was the most prevalent 
factor in mastalgia occurrence.  Seventeen percent of women reported that their 
mastalgia interfered with their exercise participation. 
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